Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris
- PMID: 19468225
- DOI: 10.1159/000219938
Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris
Abstract
Objectives: The antianginal and anti-ischemic efficacy of ivabradine has been demonstrated in large-scale trials. Pooling trial data allowed for subpopulation analyses of ivabradine's antianginal efficacy.
Methods: Data on the frequency of angina attacks, short-acting nitrate consumption, and heart rate were pooled from 5 randomized trials in patients with stable angina pectoris receiving 5, 7.5, or 10 mg of ivabradine b.i.d. for 3 or 4 months. The subpopulations were defined according to age, sex, disease characteristics, and comorbidities (severity of angina, history of myocardial infarction, cerebrovascular disease, revascularization status, diabetes, asthma/chronic obstructive pulmonary disease, or peripheral vascular disease).
Results: Efficacy data were available for 2,425 patients (full analysis set), in whom ivabradine reduced the frequency of diary-based angina attacks by 59.4% and nitrate consumption by 53.7%. All subpopulations experienced 51-70% reductions in the frequency of angina attacks, with similar reductions for the other parameters studied. Ivabradine's efficacy was maintained in the presence of different comorbidities. In the safety set, ivabradine reduced heart rate by 14.5%. Ivabradine had a good safety and tolerability profile in all the subpopulations assessed.
Conclusions: The antianginal efficacy of ivabradine was consistent across all the subpopulations analyzed, independent of the severity of angina and the presence of a comorbidity.
Copyright 2009 S. Karger AG, Basel.
Similar articles
-
Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study.Am Heart J. 2009 Oct;158(4):e51-7. doi: 10.1016/j.ahj.2009.06.008. Am Heart J. 2009. PMID: 19781403 Clinical Trial.
-
Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus.Am J Cardiol. 2010 Jan 1;105(1):29-35. doi: 10.1016/j.amjcard.2009.08.642. Epub 2009 Nov 10. Am J Cardiol. 2010. PMID: 20102886 Clinical Trial.
-
Long-term safety and efficacy of ivabradine in patients with chronic stable angina.Cardiology. 2007;108(4):387-96. doi: 10.1159/000108387. Epub 2007 Sep 21. Cardiology. 2007. PMID: 17890862 Clinical Trial.
-
Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.Am J Ther. 2008 Sep-Oct;15(5):461-73. doi: 10.1097/MJT.0b013e3181758855. Am J Ther. 2008. PMID: 18806523 Review.
-
Ivabradine: beyond heart rate control.Adv Ther. 2009 Jan;26(1):12-24. doi: 10.1007/s12325-008-0130-y. Epub 2009 Jan 22. Adv Ther. 2009. PMID: 19165437 Review.
Cited by
-
Role of ivabradine in management of stable angina in patients with different clinical profiles.Open Heart. 2018 Mar 9;5(1):e000725. doi: 10.1136/openhrt-2017-000725. eCollection 2018. Open Heart. 2018. PMID: 29632676 Free PMC article. Review.
-
Stable angina pectoris: antianginal therapies and future directions.Nat Rev Cardiol. 2011 Aug 30;9(1):40-52. doi: 10.1038/nrcardio.2011.129. Nat Rev Cardiol. 2011. PMID: 21878880 Review.
-
Ivabradine for the treatment of stable angina pectoris in octogenarians.Clin Res Cardiol. 2011 Feb;100(2):121-8. doi: 10.1007/s00392-010-0220-0. Epub 2010 Sep 6. Clin Res Cardiol. 2011. PMID: 20821016 Clinical Trial.
-
Efficacy and Safety of Ivabradine in Combination with Beta-Blockers in Patients with Stable Angina Pectoris: A Systematic Review and Meta-analysis.Adv Ther. 2022 Sep;39(9):4189-4204. doi: 10.1007/s12325-022-02222-1. Epub 2022 Jul 17. Adv Ther. 2022. PMID: 35842897 Free PMC article.
-
Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention.Adv Ther. 2015 Feb;32(2):120-37. doi: 10.1007/s12325-015-0182-8. Epub 2015 Feb 17. Adv Ther. 2015. PMID: 25687888 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical